The role of clinical trials in the development of pharmaceutical science

Le résumé fourni par la source

The objective: to analyze the impact of modern clinical trials (CTs) on the development of pharmaceutical science to provide patients with effective and safe medicines.Materials and methods. The bibliosemantic method was used to standardize the functions of international regulatory institutions, in particular the Food and Drug Administration and European Medicines Agency, which require strict adherence to the principles of Good Clinical Practice and International Council for Harmonisation guidelines, which guarantees the ethics, reliability and reproducibility of CTs. Modern CT methodology is based on the use of randomization, double-blind control, the definition of control groups and ensuring sufficient statistical significance. Such approaches allow to minimize the systematic errors and ensure the validity of the results.Results. The article presents analytical data on CTs as a basic component of pharmaceutical science, which contributes to the transformation of fundamental scientific ideas into practical therapeutic solutions. The modern methodology of CTs is highlighted, innovative processes for forming the design of CTs are shown, including adaptive and digital approaches.Conclusions. CTs play a central role in the development of modern pharmaceutical science, facilitating the transition from basic research to the creation of effective and safe medicines. In modern conditions, their evolution is determined by the introduction of artificial intelligence, personalized medicine, decentralized approaches and digital monitoring technologies. The integration of innovative methods, adaptive research designs, as well as ensuring data transparency and adherence to high ethical standards form a new paradigm of clinical studies and contribute to the sustainable, technology-driven development of the pharmaceutical industry.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.